Terms: = Liver cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Prognosis
66 results:
1. Inhibition of RhoGEF/rhoa alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma.
Zhou HM; Chen DH; Diao WJ; Wu YF; Zhang JG; Zhong L; Jiang ZY; Zhang X; Liu GL; Li Q
Exp Cell Res; 2024 Mar; 436(1):113956. PubMed ID: 38341081
[TBL] [Abstract] [Full Text] [Related]
2. Direct interaction of platelet with tumor cell aggravates hepatocellular carcinoma metastasis by activating TLR4/ADAM10/CX3CL1 axis.
Gao JH; He AD; Liu LM; Zhou YJ; Guo YW; Lu M; Zeng XB; Gong X; Lu YJ; Liang HF; Zhang BX; Ma R; Zhang RY; Ming ZY
Cancer Lett; 2024 Mar; 585():216674. PubMed ID: 38280480
[TBL] [Abstract] [Full Text] [Related]
3. CDCA8 Facilitates Tumor Proliferation and Predicts a Poor prognosis in Hepatocellular Carcinoma.
Cui Y; Jiang N
Appl Biochem Biotechnol; 2024 Mar; 196(3):1481-1492. PubMed ID: 37428386
[TBL] [Abstract] [Full Text] [Related]
4. Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy.
Uojima H; Chuma M; Hidaka H; Tsuda T; Kobayashi S; Hattori N; Ogushi K; Arase Y; Take A; Sakaguchi Y; Tomoko A; Nishigori S; Wanatanbe T; Numata K; Morimoto M; Kagawa T; Kako M; Kusano C
Eur J Gastroenterol Hepatol; 2023 Aug; 35(8):865-873. PubMed ID: 37395239
[TBL] [Abstract] [Full Text] [Related]
5. The dynamics of telomere length in primary and metastatic colorectal cancer lesions.
Kroupa M; Kubecek O; Tomasova K; Hanak P; Krupova M; Cervena K; Siskova A; Rosendorf J; Hosek P; Vodickova L; Vodicka P; Liska V; John S; Vymetalkova V; Petera J
Sci Rep; 2023 Jun; 13(1):9097. PubMed ID: 37277368
[TBL] [Abstract] [Full Text] [Related]
6. The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion.
Liu J; Zhuang G; Bai S; Hu Z; Xia Y; Lu C; Wang J; Wang C; Liu L; Li F; Wu Y; Shen F; Wang K
Oncologist; 2023 Nov; 28(11):e1043-e1051. PubMed ID: 37196175
[TBL] [Abstract] [Full Text] [Related]
7. Septin11 promotes hepatocellular carcinoma cell motility by activating rhoa to regulate cytoskeleton and cell adhesion.
Fu L; Wang X; Yang Y; Chen M; Kuerban A; Liu H; Dong Y; Cai Q; Ma M; Wu X
Cell Death Dis; 2023 Apr; 14(4):280. PubMed ID: 37080972
[TBL] [Abstract] [Full Text] [Related]
8. Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study.
Zhang XP; Xu S; Lin ZY; Gao QL; Wang K; Chen ZL; Yan ML; Zhang F; Tang YF; Zhao ZM; Li CG; Lau WY; Cheng SQ; Hu MG; Liu R
Int J Surg; 2023 Apr; 109(4):679-688. PubMed ID: 36917129
[TBL] [Abstract] [Full Text] [Related]
9. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
[TBL] [Abstract] [Full Text] [Related]
10. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
11. 13 C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Gairing SJ; Kuchen R; Müller L; Cankaya A; Weerts J; Kapucu A; Sachse S; Zimpel C; Stoehr F; Pitton MB; Mittler J; Straub BK; Marquardt JU; Schattenberg JM; Labenz C; Kloeckner R; Weinmann A; Galle PR; Wörns MA; Foerster F
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00529. PubMed ID: 36087052
[TBL] [Abstract] [Full Text] [Related]
12. The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.
Ke Q; Xin F; Fang H; Zeng Y; Wang L; Liu J
Front Immunol; 2022; 13():913464. PubMed ID: 35677059
[TBL] [Abstract] [Full Text] [Related]
13. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract] [Full Text] [Related]
14. Long disease-free interval diminishes the prognostic value of primary tumor stage for patients with colorectal cancer liver metastases.
Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
HPB (Oxford); 2022 May; 24(5):737-748. PubMed ID: 35123859
[TBL] [Abstract] [Full Text] [Related]
15. A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways.
Shirin M; Madadi S; Peyravian N; Pezeshkian Z; Rejali L; Hosseini M; Moradi A; Khanabadi B; Sherkat G; Aghdaei HA; Nazemalhosseini-Mojarad E
Med Oncol; 2022 Jan; 39(4):40. PubMed ID: 35092502
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
17. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.
Wang H; Ding Y; Chen Y; Jiang J; Chen Y; Lu J; Kong M; Mo F; Huang Y; Zhao W; Fang P; Chen X; Teng X; Xu N; Lu Y; Yu X; Li Z; Zhang J; Wang H; Bao X; Zhou D; Chi Y; Zhou T; Zhou Z; Chen S; Teng L
Gastric Cancer; 2021 Nov; 24(6):1227-1241. PubMed ID: 34095982
[TBL] [Abstract] [Full Text] [Related]
18. Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis.
Li J; Tian L; Jing Z; Guo Z; Nan P; Liu F; Zou S; Yang L; Xie X; Zhu Y; Zhao Y; Sun W; Sun Y; Zhao X
Cancer Lett; 2021 Sep; 516():13-27. PubMed ID: 34062216
[TBL] [Abstract] [Full Text] [Related]
19. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
20. MicroRNA‑125a‑5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1.
Zha Z; Li J
Int J Mol Med; 2020 Nov; 46(5):1849-1861. PubMed ID: 33000203
[TBL] [Abstract] [Full Text] [Related]
[Next]
